Production & Manufacturing
Articles
Evolving Consumer and Doctor Preferences Driving Changes to Preservative-Free Multidose Eyedropper Market
Ophthalmic health has become a growing concern for many reasons – expanding elderly population, air pollution and urban populations to name a few.
Not surprisingly, there’s been a growth in products and therapies designed to help ophthalmic issues. In 2017,...
Production & Manufacturing
DuPont Achieves Major Milestone to Expand Probiotics Capacity
DuPont announced it has completed construction on a new, state-of-the art probiotics fermentation unit at its Rochester, New York, facility. The unit, now largest in the world, is part of a multiphase nearly $100 million investment...
Production & Manufacturing
WuXi STA’s new drug product manufacturing facility passes first European MPA GMP Inspection
STA Pharmaceutical Co., Ltd., (WuXi STA) – a subsidiary of WuXi AppTec – announces that its new drug product manufacturing facility in Waigaoqiao Free Trade Zone of Shanghai has passed its first GMP inspection by the European Medical Products...
Production & Manufacturing
WuXi STA and Ark Biosciences Sign CMC Development and Manufacturing Agreement
STA Pharmaceutical Co., Ltd., – a subsidiary of WuXi AppTec – and Ark Biosciences, a global biotech company focusing on innovative drug discovery and development, especially in the area of viral infection and respiratory disease, today announced a strategic...
Production & Manufacturing
MedPharm accelerates strategy to broaden service offering into commercial manufacturing
MedPharm Ltd, a leading contract provider of topical and transdermal product design and development services, has announced two new appointments to its Board to support plans to grow its commercial manufacturing services. The new members, Paul...
Articles
Technology transfer for a Good management are keys for considerable experience in transferring aseptic processes and systems
There are many reasons for pharma and biotech companies for a technology transfer: Some need a back-up strategy for risk management to provide an adequate market supply for the patient.
For others, there may be a lack of appropriate resources/capacity...
Production & Manufacturing
Norvartis invests $115M more in biotech AveXis to double manufacturing
AveXis, a gene therapy company developing treatments for rare and life-threatening neurological diseases that Novartis bought in an $8.7 billion deal, will be creating 200 jobs as it expands its manufacturing center in Durham County, North Carolina. ...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from any location or device.
Must read
